Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 48

1.

Genomic Epidemiology of Campylobacter jejuni Transmission in Israel.

Rokney A, Valinsky L, Moran-Gilad J, Vranckx K, Agmon V, Weinberger M.

Front Microbiol. 2018 Oct 16;9:2432. doi: 10.3389/fmicb.2018.02432. eCollection 2018.

2.

Dissemination of the Methicillin-resistant Staphylococcus aureus Pediatric Clone (ST5-T002-IV-PVL+) as a Major Cause of Community-associated Staphylococcal Infections in Bedouin Children, Southern Israel.

Rokney A, Baum M, Ben-Shimol S, Sagi O, Anuka E, Agmon V, Greenberg D, Valinsky L, Danino D.

Pediatr Infect Dis J. 2019 Mar;38(3):230-235. doi: 10.1097/INF.0000000000002126.

PMID:
29912846
3.

Ambient temperature and age-related notified Campylobacter infection in Israel: A 12-year time series study.

Rosenberg A, Weinberger M, Paz S, Valinsky L, Agmon V, Peretz C.

Environ Res. 2018 Jul;164:539-545. doi: 10.1016/j.envres.2018.03.017. Epub 2018 Mar 31.

PMID:
29609183
4.

Emergence of Streptococcus pneumoniae Serotype 12F after Sequential Introduction of 7- and 13-Valent Vaccines, Israel.

Rokney A, Ben-Shimol S, Korenman Z, Porat N, Gorodnitzky Z, Givon-Lavi N, Ron M, Agmon V, Dagan R, Valinsky L.

Emerg Infect Dis. 2018 Mar;24(3):453-461. doi: 10.3201/eid2403.170769.

5.

Real-time genomic investigation underlying the public health response to a Shiga toxin-producing Escherichia coli O26:H11 outbreak in a nursery.

Moran-Gilad J, Rokney A, Danino D, Ferdous M, Alsana F, Baum M, Dukhan L, Agmon V, Anuka E, Valinsky L, Yishay R, Grotto I, Rossen JWA, Gdalevich M.

Epidemiol Infect. 2017 Oct;145(14):2998-3006. doi: 10.1017/S0950268817001923. Epub 2017 Sep 19.

PMID:
28925349
6.

Contribution of real-time PCR to Plasmodium species identification and to clinical decisions: a nationwide study in a non-endemic setting.

Grossman T, Schwartz E, Vainer J, Agmon V, Glazer Y, Goldmann D, Marva E.

Eur J Clin Microbiol Infect Dis. 2017 Apr;36(4):671-675. doi: 10.1007/s10096-016-2844-0. Epub 2016 Dec 13.

PMID:
27966198
7.

Molecular epidemiology of Campylobacter jejuni infection in Israel-a nationwide study.

Weinberger M, Moran-Gilad J, Rokney A, Davidov Y, Agmon V, Peretz C, Valinsky L.

Clin Microbiol Infect. 2016 Dec;22(12):1005.e9-1005.e15. doi: 10.1016/j.cmi.2016.08.014. Epub 2016 Sep 9.

8.

Near real-time space-time cluster analysis for detection of enteric disease outbreaks in a community setting.

Glatman-Freedman A, Kaufman Z, Kopel E, Bassal R, Taran D, Valinsky L, Agmon V, Shpriz M, Cohen D, Anis E, Shohat T.

J Infect. 2016 Aug;73(2):99-106. doi: 10.1016/j.jinf.2016.04.038. Epub 2016 Jun 14.

PMID:
27311747
9.

Trends in the Epidemiology of Campylobacteriosis in Israel (1999-2012).

Bassal R, Lerner L, Valinsky L, Agmon V, Peled N, Block C, Keller N, Keness Y, Taran D, Shainberg B, Ken-Dror S, Treygerman O, Rouach T, Lowenthal S, Shohat T, Cohen D.

Foodborne Pathog Dis. 2016 Aug;13(8):448-55. doi: 10.1089/fpd.2015.2096. Epub 2016 May 20.

PMID:
27203409
10.

Design and application of a core genome multilocus sequence typing scheme for investigation of Legionnaires' disease incidents.

Moran-Gilad J, Prior K, Yakunin E, Harrison TG, Underwood A, Lazarovitch T, Valinsky L, Luck C, Krux F, Agmon V, Grotto I, Harmsen D.

Euro Surveill. 2015 Jul 16;20(28). pii: 21186.

11.

Greywater use in Israel and worldwide: standards and prospects.

Oron G, Adel M, Agmon V, Friedler E, Halperin R, Leshem E, Weinberg D.

Water Res. 2014 Jul 1;58:92-101. doi: 10.1016/j.watres.2014.03.032. Epub 2014 Mar 22.

PMID:
24747140
12.

Integrative analysis of Salmonellosis in Israel reveals association of Salmonella enterica Serovar 9,12:l,v:- with extraintestinal infections, dissemination of endemic S. enterica Serovar Typhimurium DT104 biotypes, and severe underreporting of outbreaks.

Marzel A, Desai PT, Nissan I, Schorr YI, Suez J, Valinsky L, Reisfeld A, Agmon V, Guard J, McClelland M, Rahav G, Gal-Mor O.

J Clin Microbiol. 2014 Jun;52(6):2078-88. doi: 10.1128/JCM.00399-14. Epub 2014 Apr 9.

13.

Recent trends in the epidemiology of shigellosis in Israel.

Cohen D, Bassal R, Goren S, Rouach T, Taran D, Schemberg B, Peled N, Keness Y, Ken-Dror S, Vasilev V, Nissan I, Agmon V, Shohat T.

Epidemiol Infect. 2014 Dec;142(12):2583-94. doi: 10.1017/S0950268814000260. Epub 2014 Feb 20.

PMID:
24559503
14.

Increased incidence of Campylobacter spp. infection and high rates among children, Israel.

Weinberger M, Lerner L, Valinsky L, Moran-Gilad J, Nissan I, Agmon V, Peretz C.

Emerg Infect Dis. 2013 Nov;19(11):1828-31. doi: 10.3201/eid1911.120900.

15.

Risk factors for sporadic infection with Salmonella Infantis: a matched case-control study.

Bassal R, Reisfeld A, Nissan I, Agmon V, Taran D, Schemberg B, Cohen D, Shohat T.

Epidemiol Infect. 2014 Apr;142(4):820-5. doi: 10.1017/S0950268813001799. Epub 2013 Jul 23.

PMID:
23879895
16.

Virulence gene profiling and pathogenicity characterization of non-typhoidal Salmonella accounted for invasive disease in humans.

Suez J, Porwollik S, Dagan A, Marzel A, Schorr YI, Desai PT, Agmon V, McClelland M, Rahav G, Gal-Mor O.

PLoS One. 2013;8(3):e58449. doi: 10.1371/journal.pone.0058449. Epub 2013 Mar 7.

17.

Geographical variations in Salmonella incidence in Israel 1997-2006: the effect of rural residency.

Weinberger M, Agmon V, Yaron S, Nissan I, Peretz C.

Epidemiol Infect. 2013 Oct;141(10):2058-67. doi: 10.1017/S0950268812002737. Epub 2012 Dec 12.

PMID:
23232093
18.

Recent trends in the epidemiology of non-typhoidal Salmonella in Israel, 1999-2009.

Bassal R, Reisfeld A, Andorn N, Yishai R, Nissan I, Agmon V, Peled N, Block C, Keller N, Kenes Y, Taran D, Schemberg B, Ken-Dror S, Rouach T, Citron B, Berman E, Green MS, Shohat T, Cohen D.

Epidemiol Infect. 2012 Aug;140(8):1446-53. doi: 10.1017/S095026881100197X. Epub 2011 Nov 1.

PMID:
22040482
19.

Multidrug-resistant Salmonella enterica serovar Infantis, Israel.

Gal-Mor O, Valinsky L, Weinberger M, Guy S, Jaffe J, Schorr YI, Raisfeld A, Agmon V, Nissan I.

Emerg Infect Dis. 2010 Nov;16(11):1754-7. doi: 10.3201/eid1611.100100.

20.

The epidemiology of extraintestinal non-typhoid Salmonella in Israel: the effects of patients' age and sex.

Zaidenstein R, Peretz C, Nissan I, Reisfeld A, Yaron S, Agmon V, Weinberger M.

Eur J Clin Microbiol Infect Dis. 2010 Sep;29(9):1103-9. doi: 10.1007/s10096-010-0968-1. Epub 2010 Jun 10.

PMID:
20535625
21.

Curtailed short-term and long-term survival following infection with non-typhoid Salmonella in Israel.

Weinberger M, Yaron S, Agmon V, Yishai R, Rosenberg A, Peretz C.

Clin Microbiol Infect. 2011 Feb;17(2):278-84. doi: 10.1111/j.1469-0691.2010.03184.x.

22.

Salmonella enterica outbreak in a banqueting hall in Jerusalem: the unseen hand of the epidemiological triangle?

Stein-Zamir C, Tallen-Gozani E, Abramson N, Shoob H, Yishai R, Agmon V, Reisfeld A, Valinsky L, Marva E.

Isr Med Assoc J. 2009 Feb;11(2):94-7.

23.

The changing panorama of bacterial enteric infections.

Stein-Zamir C, Shoob H, Abramson N, Zentner G, Agmon V.

Epidemiol Infect. 2009 Nov;137(11):1531-7. doi: 10.1017/S095026880900243X. Epub 2009 Mar 19.

PMID:
19296872
24.

Clinical characteristics and molecular subtyping of Vibrio vulnificus illnesses, Israel.

Zaidenstein R, Sadik C, Lerner L, Valinsky L, Kopelowitz J, Yishai R, Agmon V, Parsons M, Bopp C, Weinberger M.

Emerg Infect Dis. 2008 Dec;14(12):1875-82. doi: 10.3201/eid1412.080499. No abstract available.

25.

A survey of laboratory-confirmed isolates of invasive listeriosis in Israel, 1997-2007.

Vasilev V, Japheth R, Andorn N, Yshai R, Agmon V, Gazit E, Kashi Y, Cohen D.

Epidemiol Infect. 2009 Apr;137(4):577-80. doi: 10.1017/S0950268808001179. Epub 2008 Sep 16.

PMID:
18796168
26.

Salmonella enterica serotype Virchow: epidemiology, resistance patterns and molecular characterisation of an invasive Salmonella serotype in Israel.

Weinberger M, Solnik-Isaac H, Shachar D, Reisfeld A, Valinsky L, Andorn N, Agmon V, Yishai R, Bassal R, Fraser A, Yaron S, Cohen D.

Clin Microbiol Infect. 2006 Oct;12(10):999-1005.

27.

Prevalence and correlates of diphtheria toxoid antibodies in children and adults in Israel.

Valinsky L, Simhoni S, Bassal R, Agmon V, Yishai R, Green MS, Cohen D.

Clin Microbiol Infect. 2006 Oct;12(10):968-73.

28.

Blood invasiveness of Salmonella enterica as a function of age and serotype.

Weinberger M, Andorn N, Agmon V, Cohen D, Shohat T, Pitlik SD.

Epidemiol Infect. 2004 Dec;132(6):1023-8.

29.

Endemic occurrence of infections by multidrug-resistant Escherichia coli of four unique serotypes in the elderly population of Israel.

Wolk M, Valinsky L, Sompolinsky D, Sechter I, Schmidt H, Tetry S, Agmon V.

FEMS Microbiol Lett. 2004 Oct 15;239(2):249-54.

30.

Variability of Shigella flexneri serotypes in Israel during a period of two years: 2000 and 2001.

Vasilev V, Andorn N, Japheth R, Agmon V.

Epidemiol Infect. 2004 Jan;132(1):51-6.

31.

Microspectrofluorometry and fluorescence imaging in the study of human cytopathology.

Kohen E, Gatt S, Schachtschabel A, Schachtschabel DO, Kohen C, Agmon V, Hirschberg JG, Monti M.

Microsc Res Tech. 2000 Dec 1;51(5):469-80.

PMID:
11074618
32.

Synthesis of fluorescent substrates and their application to study of sphingolipid metabolism in vitro and in intact cells.

Dagan A, Agmon V, Gatt S, Dinur T.

Methods Enzymol. 2000;312:293-304. No abstract available.

PMID:
11070879
33.

Nontyphoid Salmonella bacteremia: age-related differences in clinical presentation, bacteriology, and outcome.

Shimoni Z, Pitlik S, Leibovici L, Samra Z, Konigsberger H, Drucker M, Agmon V, Ashkenazi S, Weinberger M.

Clin Infect Dis. 1999 Apr;28(4):822-7.

PMID:
10825045
34.

Clinical, epidemiological, and microbiological features of Vibrio vulnificus biogroup 3 causing outbreaks of wound infection and bacteraemia in Israel. Israel Vibrio Study Group.

Bisharat N, Agmon V, Finkelstein R, Raz R, Ben-Dror G, Lerner L, Soboh S, Colodner R, Cameron DN, Wykstra DL, Swerdlow DL, Farmer JJ 3rd.

Lancet. 1999 Oct 23;354(9188):1421-4.

PMID:
10543668
35.

Multiprobe fluorescence imaging and microspectrofluorimetry of cell transformation and differentiation: implications in terms of applied biochemistry and biotechnology.

Kohen E, Gatt S, Schachtschabel A, Schachtschabel DO, Kohen C, Agmon V, Hirschberg JG, Monti M, Roisen F.

Biotechnol Appl Biochem. 1999 Jun;29 ( Pt 3):191-205.

PMID:
10334948
36.
37.

Photosensitized inactivation of Plasmodium falciparum- and Babesia divergens-infected erythrocytes in whole blood by lipophilic pheophorbide derivatives.

Grellier P, Santus R, Mouray E, Agmon V, Mazière JC, Rigomier D, Dagan A, Gatt S, Schrével J.

Vox Sang. 1997;72(4):211-20.

PMID:
9228710
38.

Overexpression of human glucocerebrosidase containing different-sized leaders.

Pasmanik-Chor M, Elroy-Stein O, Aerts H, Agmon V, Gatt S, Horowitz M.

Biochem J. 1996 Jul 1;317 ( Pt 1):81-8.

39.

Intracellular degradation of sulforhodamine-GM1: use for a fluorescence-based characterization of GM2-gangliosidosis variants in fibroblasts and white blood cells.

Agmon V, Khosravi R, Marchesini S, Dinur T, Dagan A, Gatt S, Navon R.

Clin Chim Acta. 1996 Mar 29;247(1-2):105-20.

PMID:
8920231
40.
41.

Sulforhodamine GM1-ganglioside: synthesis and physicochemical properties.

Marchesini S, Demasi L, Cestone P, Preti A, Agmon V, Dagan A, Navon R, Gatt S.

Chem Phys Lipids. 1994 Aug 8;72(2):143-52.

PMID:
7954976
43.

Diagnosing sphingolipidoses in murine and human embryos.

Epstein M, Avital Y, Agmon V, Dinur T, Fibach E, Gatt S, Laufer N.

Hum Reprod. 1993 Feb;8(2):302-9.

PMID:
8473438
44.

A novel fluorescent pH indicator for the acidic range.

Marchesini S, Gatt S, Agmon V, Giudici ML, Monti E.

Biochem Int. 1992 Jul;27(3):545-50.

PMID:
1417891
45.

Administration of pyrene lipids by receptor-mediated endocytosis and their degradation in skin fibroblasts.

Agmon V, Dinur T, Cherbu S, Dagan A, Gatt S.

Exp Cell Res. 1991 Oct;196(2):151-7.

PMID:
1654269
46.

Induction of SOS functions by alkaline intracellular pH in Escherichia coli.

Schuldiner S, Agmon V, Brandsma J, Cohen A, Friedman E, Padan E.

J Bacteriol. 1986 Nov;168(2):936-9.

47.

Escherichia coli intracellular pH, membrane potential, and cell growth.

Zilberstein D, Agmon V, Schuldiner S, Padan E.

J Bacteriol. 1984 Apr;158(1):246-52.

48.

The sodium/proton antiporter is part of the pH homeostasis mechanism in Escherichia coli.

Zilberstein D, Agmon V, Schuldiner S, Padan E.

J Biol Chem. 1982 Apr 10;257(7):3687-91. No abstract available.

Supplemental Content

Support Center